Last Updated:

Sunday, October 2, 2022

4:14 PM

Germany

BioNTech

BioNTech SE focuses on the development of molecular immune therapies and biomarker-based diagnostic approaches.

BioNTech SE focuses on the development of molecular immune therapies and biomarker-based diagnostic approaches.

Newsroom